A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia
EARLY_PHASE1
This is an investigator-initiated trial to evaluate the safety and efficacy...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology